Burden of concomitant asthma and COPD in a Medicaid population

Chest

Volumn 134, Issue 1, 2008, Pages 14-19

  Shaya, Fadia T ^a,b   Dongyi, Du ^b   Akazawa, Manabu O ^c   Blanchette, Christopher M ^d   Wang, Jingshu ^b   Mapel, Douglas W ^e   Dalal, Anand ^d   Scharf, Steven M ^f  

^a Pharmaceutical Hlth Serv Res D   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d GLAXOSMITHKLINE   (United States)

^e LOVELACE CLINIC FOUNDATION   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

Author keywords

Asthma; COPD; Medicaid; Medical utilization

Indexed keywords

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL FEE; MEDICAL SERVICE; OUTPATIENT CARE; PRIORITY JOURNAL;

EID: 47549101097     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-2317     Document Type: Article

References (18)

1. Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59:469-478
2. National Heart, Lung, and Blood Institute. Morbidity and mortality: 2004 chartbook on cardiovascular, lung, and blood diseases. Washington, DC: US Department of Health and Human Services, 2004
3. World Health Organization. COPD: definition. Available at: http://www.who.int/respiratory/copd/definition/en/. Accessed March 2, 2008
4. National Center for Health Statistics. National health interview survey. Washington, DC: Department of Health and Human Services, 2001
5. National Heart, Lung, and Blood Institute. Data fact sheet: chronic obstructive pulmonary disease. Bethesda, MD: US Department of Health and Human Services, 2003; National Institutes of Health Publication 03-5229
6. National Institute for Clinical Excellence. Chronic obstructive pulmonary disease: clinical guideline 12. Available at: http://www.nice.org.uk/nicemedia/ pdf/CG012_niceguideline. pdf. Accessed June 19, 2008
7. Pawar V, Smith MJ. Asthma-related healthcare services utilization by African-Americans enrolled in West Virginia Medicaid. Respir Med 2006; 100:1579-1587
8. Sapra S, Nielsen K, Martin BC. The net cost of asthma to North Carolina Medicaid and the influence of comorbidities that drive asthma costs. J Asthma 2005; 42:469-477
9. Valerio M, Cabana MD, White DF, et al. Understanding of asthma management: Medicaid parents' perspectives. Chest 2006; 129:594-601
10. Darkow T, Kadlubek PJ, Shah H, et al. A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease. J Occup Environ Med 2007; 49:22-30
11. Schermer TRJ, Saris CGJ, van den Bosch WJHM, et al. Exacerbations and associated healthcare cost in patients with COPD in general practice. Monaldi Arch Chest Dis 2006; 65:133-140
12. Maniadakis N, Tzanakis N, Fragoulakis V, et al. Economic evaluation of tiotropium and salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) in Greece. Curr Med Res Opin 2006; 22:1599-1607
13. The Henry J. Kaiser Family Foundation. Maryland state Medicaid fact sheets, 2004-2005 Available at: http://www. kff.org/. Accessed March 3, 2008
14. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383
15. Martinez-Castelao A, Gorriz JL, Garcia-Lopez F, et al. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study). J Nephrol 2004; 17:544-551
16. Glynn RJ, Knight EL, Levin R, et al. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology 2001; 12:682-689
17. Marton JP, Boulanger L, Friedman M, et al. Assessing the costs of chronic obstructive pulmonary disease: the state Medicaid perspective. Respir Med 2006; 100:996-1005
18. Cisternas MG, Blanc PD, Yen IH, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 2003; 111:1212-1218